Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heterologous vs Homologous AZ and Moderna Vaccination
NCT05074368Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2021
- Primary completion
- Apr 2022
- Modality
- Viral Vector Vaccines, mRNA Therapeutics
- Countries
- 1
01
Overview
Open-label trial of ChAdOx1 nCoV-19 and elasomeran in coronavirus disease 2019 (COVID-19), sponsored by National Taiwan University Hospital. Started Jul 2021; status: completed.
02
Drugs
ChAdOx1 nCoV-19elasomeran
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05074368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05074368.